Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease-Reference-Cited by-同舟云学术

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease

Published:2013-10-21 Issue:5 Volume:76 Page:734-740
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Puisset Florent¹²,White-Koning Mélanie²,Kamar Nassim³⁴,Huart Antoine³,Haberer Frédérique²,Blasco Hélène⁵,Le Guellec Chantal⁶,Lafont Thierry²,Grand Anaïs¹,Rostaing Lionel³⁴,Chatelut Etienne²,Pourrat Jacques³

Affiliation:

1. Pharmacie; Centre Hospitalier Universitaire; Toulouse France

2. EA4553; Université Paul Sabatier and Institut Claudius-Regaud; Toulouse France

3. Département de néphrologie et transplantation d'organe CHU Rangueil; Toulouse France

4. INSERM U1043; IFR-BMT; CHU Purpan; Toulouse France

5. Laboratoire de Biochimie et Biologie Moléculaire; CHU de Tours; INSERM U930; Université François Rabelais; Tours France

6. EA4245 ‘Cellules dendritiques, immunomodulation et greffes’; Université François Rabelais; de Tours France

Funder

Hoffman Laroche

Association pour la Recherche en Transfusion (ART)

Association Midi-Pyrénées Santé

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12098/fullpdf

Reference29 articles.

1. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998

2. B lymphocyte depletion therapy with rituximab in rheumatoid arthritis;Edwards;Rheum Dis Clin North Am,2004

3. The spectrum of use of rituximab in chronic lymphocytic leukemia;Tedeschi;Onco Targets Ther,2010

4. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma;Keating;Drugs,2010

5. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders;George;J Clin Apher,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis;Biomedicine & Pharmacotherapy;2024-06

2. Nephrologisches Management und Medikamentendosierung bei Rheumapatienten mit Niereninsuffizienz – Teil 2;Rheuma Plus / Schweiz;2024-03-08

3. Case report: renal recovery in Goodpasture’s syndrome treated with rituximab;Journal of Nephrology;2024-03-01

4. Therapeutic apheresis in renal transplantation: An update;Transfusion and Apheresis Science;2023-11

5. Therapeutic apheresis in renal transplantation: An update;Transfusion and Apheresis Science;2023-11